Catalyst Wire Dossier Catalyst Wire Dossier

Adalimumab (FITC-conjugated)

adalimumab · AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adalimumab (FITC-conjugated), covering 2012-09-14 to 2012-09-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut [Phase 1, Phase 2]

See pricing